您的位置: 首页 > 农业专利 > 详情页

ANTI-CTLA4 MONOCLONAL ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF, MEDICINAL COMPOSITION AND USE.
专利权人:
INC.;AKESO BIOPHARMA
发明人:
LI, Baiyong,PANG, Xinghua,WANG, Zhongmin,XIA, Yu,ZHANG, Peng
申请号:
TN2017000010
公开号:
TN2017000010A1
申请日:
2015.07.31
申请国别(地区):
TN
年份:
2018
代理人:
摘要:
The present invention belongs to the fields of tumor treatment and molecular immunology and provides an anti-CTLA4 monoclonal antibody or an antigen binding fragment thereof, a medicinal composition thereof, and a use thereof. The monoclonal antibody of the present invention blocks CTLA4 from binding to B7, thereby eliminating the immunosuppressive effect of CTLA4 on the host and activating T lymphocytes.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充